Delays to store openings and 'unforeseen' regulatory issues have caused the firm to rein in its earnings projections for the year
Legalization means additional tax revenue on legal weed, social security contributions as well as savings in law enforcement
But net income soared due to a US$69M value gain on warrants
The firm blamed the drop in part on 'seasonal weakness'
The 16-month investigation led to 21 arrests and 118 charges
Currently only a handful of Canadian nurseries supply genetics to hundreds of licensed pot producers
But concerns remain around its significant debt pile and an inability to pay it off
The firm upped Q3 revenue by 17% but tallied a $13.5M loss
Rose is a third-party supplier for major cannabis companies and micros in Quebec
Police estimate the value of the raid at $3.7M
Particularly the firm's new retail acquisition is turning a profit
The firm is selling in 12 international markets and has added eight more product listings in Canada
The firm is projecting revenues to rise another 9% in Q4
During arrests this year, police said they found hundreds of text messages with pictures of customer IDs
But it's unclear how the bill will do in the upper house, and the Bolsonaro administration opposes cannabis use
The leading US weed firm continues to post solid growth and fundamentals
Colorado has the first state-sanctioned sporting regulator to recognize cannabis as medicine
The company says a majority of new sales growth is coming from its focus on medical cannabis
Net loss ballooned 507% to US$59 million this fiscal period due to rising expenses
Company stock soared 12% on Tuesday
Around 155 employees will be impacted by the decision to shut down the facilities and centralize operations
While pleased with a growing acceptance of cannabis, Anutin Charnvirakul is promising greater access
Citizen Stash shareholders approved the deal in a special meeting Nov. 1
The Netherlands could have Europe's first adult-use cannabis market
Cannabis sales have been 25% higher than estimated revenue if the pandemic didn't happen
Q2 revenue dipped 6% to $146M
Ending the provincial monopoly of online sales and delivery is being welcomed by those in Alberta's cannabis industry
The line of skincare products is created in partnership with Israel-based Nextage Therapeutics
Support for legalization remains high, a new poll shows, with more than two-thirds of Americans in favour
The firm says it can now export biomass and flower to its international clients
The company says it will use data from its clinics in Colombia and Peru to help treat patients in the UK
HYTN's sparkling THC-infused drinks are expected to be on the shelves before the end of the year
A citrus soda and two gummy flavours, all with 10mg of THC, will be available to Canadians
The state's cannabis law allows for sales to start in 2022, but weed stores won't be selling until mid-2023
The transaction is expected to close around Nov. 15
The firm says it's looking for solutions to debt obligations it continues to be in default of
The firm's beverage sales are up 66% and the rest of its adult-use segment grew 31% this quarter
Columbia Care will produce, distribute and sell the celebrity-backed brand
THC-infused mints and cranberry sauce vapes will be hitting shelves in select provinces this November
Legal weed sales went up 13% after little growth reported in the previous quarter







































